Researchers at the University of Miami Miller School of Medicine have developed the Brain Health Platform, an advanced series of tests to determine a patient’s dementia risk. The platform combines three measures: a Resilience Index (RI), a Vulnerability Index (VI), and a Number-Symbol Coding Task (NSCT). When combined, these metrics help triangulate a patient’s risk of developing Alzheimer’s and other neurological conditions. The work was recently published in the Journal of Alzheimer’s Disease.
Click the image below for full article.